This federal drug discount program is actually boosting cancer care costs
(By Debra Patt for ST A T) G iven its name, you’d expect the federal 340B Drug Discount Program 1
Read More(By Debra Patt for ST A T) G iven its name, you’d expect the federal 340B Drug Discount Program 1
Read More(By Ed Silverman for ST A T) S omeone at Nippon Fine Chemical must have been very nervous when an
Read More(By Rhitu Chatterjee for NPR) Diet and nutrition are now the biggest risk factors for people’s health across the globe,
Read More(By Virginia Anderson for NPR) Shela Bryan, 63, has been comparing prices for individual health insurance plans since May, and
Read More(By Melissa Quinn for The Daily Signal) Republican Rep. Chris Stewart of Utah has mounted a campaign urging House Speaker
Read More(By Ed Silverman for ST A T) A t a time when drug makers are under intense scrutiny for their
Read More(‘By Ed Silverman for ST A T) M ylan reached a $465 million settlement on Friday with the US Department
Read More(By Meghana Keshavan for ST A T) The race to create the next potent ovarian cancer drug is coming to
Read MoreThe outsourcing of Chronic Care Management to external technology-based firms is explored in an article posted www.healthcare-informatics.com by David Raths.
Read More(By Emily Kopp for Kaiser Health News) As Zika skipped into Puerto Rico and then Florida this summer and threatened
Read More